Fig. 4
From: Progress and challenges towards targeted delivery of cancer therapeutics
Challenges to clinical translation of stimuli-responsive NCs. Controlled-switch NCs designed to prevent premature drug release face challenges associated with the type of stimulus on which they are based. Other than that, additional design challenges for the NCs themeselves include scalability, sensitivity, and response to the stimulus, biocompatibility, and toxicity
